Acute Care and Trauma Flashcards

1
Q

<p>Define acute kidney injury (AKI).</p>

A

<p>Acute kidney injury was previously known as acute renal failure (ARF). It is characterised by an <strong>ACUTE DECLINE IN RENAL FUNCTION</strong>. This leads to an increase in serum creatinine and a decrease in urine production/outflow.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

<p>Explain the aetiology/risk factors of acute kidney injury (AKI).</p>

<p></p>

A

<p>Sepsis<br></br>Cardiovascular collapse<br></br>Congestive heart failure<br></br>Major surgery<br></br>Nephrotoxins (such as antibiotics, intravenous contrast, or other drugs)<br></br>Urinary outflow obstruction</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

<p>Summarise the epidemiology of acute kidney injury (AKI).</p>

A

<p>Among people hospitalised in 2014 with AKI, 40% also had diabetes.<br></br>In the intensive care unit (ICU), the incidence of AKI is higher.<br></br>Acute tubular necrosis (ATN) accounts for 45% of cases of AKI.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

<p>Recognise the presenting symptoms of acute kidney injury (AKI). Recognise the signs of acute kidney injury (AKI) on physical examination.</p>

<p></p>

<p></p>

A

<p>Flank pain<br></br>Haematuria<br></br>Oedema<br></br>Lethargy<br></br>Uraemia<br></br>Decreased urine output<br></br>AKI can be asymptomatic and is usually defined by lab tests.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

<p>Identify appropriate investigations for acute kidney injury (AKI) and interpret the results.</p>

A

<p>Basic metabolic profile (including urea and creatinine). Ratio of serum urea to creatinine.<br></br>Urinalysis.<br></br>Urine culture<br></br>FBC<br></br>Fractional excretion of sodium<br></br>Fractional excretion of urea<br></br>Urinary eosinophil count<br></br>Venous blood gases<br></br>Fluid challenge<br></br>Bladder catheterisation<br></br>Urine osmolality<br></br>Urine sodium concentration<br></br>CXR, ECG</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

<p>Generate a management plan for acute kidney injury (AKI).<br></br></p>

A

<p>Treat the underlying cause</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

<p>Identify the possible complications of acute kidney injury (AKI) and its management.<br></br></p>

A

<p>- Hyperkalaemia<br></br>- Heart failure<br></br>Give calcium gluconate to stabilise the myocardium. Then give a bolus of insulin with 20% dextrose, 100ml.</p>

<p>- Uraemia<br></br>- Metabolic acidosis<br></br>Give dialysis.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

<p>Summarise the prognosis for patients with acute kidney injury (AKI).<br></br></p>

A

<p>Recovery for AKI is variable and depends on the cause of injury and the severity and duration of AKI.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

<p>Define acute respiratory distress syndrome.<br></br></p>

A

<p>Acute respiratory distress syndrome (ARDS) is a <strong>NON-CARDIOGENIC PULMONARY OEDEMA</strong> and <strong>DIFFUSE LUNG INFLAMMATION SYSTEM</strong> that often complicates critical illness.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

<p>Explain the aetiology/risk factors of acute respiratory distress syndrome.<br></br></p>

A

<p> Sepsis with pulmonary origin.

Other conditions associated with ARDS include aspiration, inhalation injury, acute pancreatitis, trauma, burns, pulmonary contusion, transfusion-related lung injury, cardiopulmonary bypass, fat embolism, disseminated intravascular coagulation, and drug overdose.<br></br></p>

<p>Critical illness, cigarette smoking, and alcohol use are predisposing factors for ARDS. </p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

<p>Summarise the epidemiology of acute respiratory distress syndrome.<br></br></p>

A

<p>Overall, 10% to 15% of patients admitted to the intensive care unit meet the criteria for ARDS, with an increased incidence among mechanically ventilated patients meeting the criteria for ARDS.<br></br>Mortality is between 40% and 50%.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

<p>Recognise the presenting symptoms of acute respiratory distress syndrome.</p>

A

<p>SOB<br></br>Fatigue<br></br>Discolouration of nails<br></br>Rapid resp rate<br></br>Tachycardia<br></br>Fever<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

<p>Recognise the signs of acute respiratory distress syndrome on physical examination.<br></br></p>

A

<p>Low oxygen saturation<br></br>Acute respiratory failure<br></br>Dyspnoea<br></br>Increased respiratory rate<br></br>Pulmonary crepitations<br></br>Low lung compliance<br></br>Fever, cough, pleuritic chest pain<br></br>(Frothy sputum)<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

<p>Identify appropriate investigations for acute respiratory distress syndrome and interpret the results.<br></br></p>

A

<p>CXR - New onset of bilateral opacities that is not fully explained by effusions, lobar/lung collapse.<br></br>ABG - A PaO₂/FiO₂ (inspired oxygen) ratio of ≤300 on positive end-expiratory pressure (PEEP) or continuous positive airway pressure (CPAP) ≥5 cm H₂O is part of the diagnostic criteria for ARDS.<br></br>Sputum culture<br></br>Blood culture<br></br>Urine culture<br></br>Amylase and lipase</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

<p>Define adrenal insufficiency.<br></br></p>

A

<p>Addison's disease, or primary adrenal insufficiency, is a disorder that affects the adrenal glands, causing decreased production of adrenocortical hormones (cortisol, aldosterone, and dehydroepiandrosterone).<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

<p>Explain the aetiology/risk factors of adrenal insufficiency. Summarise the epidemiology of adrenal insufficiency.<br></br></p>

A

<p>TB is the most common cause worldwide, but in the UK, the most common cause is autoimmune disease.<br></br>Less common causes are infections (e.g. Pseudomonas aeruginosa or meningococcus) or drugs (e.g. warfarin).<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

<p>Recognise the presenting symptoms of adrenal insufficiency.<br></br></p>

A

<p>Fatigue<br></br>Anorexia<br></br>Weight loss<br></br>Hyperpigmentation<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

<p>Recognise the signs of adrenal insufficiency on physical examination.<br></br></p>

A

<p>Hypotension (can be Addisonian crisis).<br></br>Nausea<br></br>Vomiting<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

<p>Identify appropriate investigations for adrenal insufficiency and interpret the results.<br></br></p>

A

<p>Serum electrolytes - hyponatraemia, hyperkalaemia, can rarely be hypercalcaemia<br></br>Blood urea<br></br>FBC - anaemia is present in 40% of patients.<br></br>Morning serum cortisol - cortisol should be high in the morning.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

<p>Generate a management plan for adrenal insufficiency.<br></br></p>

A

<p><strong>ACUTE</strong><br></br>IV Hydrocortisone 50-100mg for 1-3 days</p>

<p><strong>STABLE</strong><br></br>Hydrocortisone: 15-30 mg/day orally given in 2 divided doses with two-thirds of the total dose given in the morning (around 8 a.m.) and one third in the afternoon (noon to 4 p.m.)<br></br>OR<br></br>Prednisolone: 2.5 to 5 mg orally once daily</p>

<p>AND</p>

<p>Fludrocortisone: 0.1 to 0.2 mg orally once daily<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

<p>Identify the possible complications of adrenal insufficiency and its management.<br></br></p>

A

<p>Hyperkalaemia: Give calcium gluconate, bolus IV insulin and 20% dextrose, 100ml.<br></br>Secondary Cushings’ syndrome: due to over-replacement of steroids.<br></br>Osteoporosis due to long term use of steroids.<br></br>Hypertension due to excessive mineralocorticoid replacement.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

<p>Summarise the prognosis for patients with adrenal insufficiency.<br></br></p>

A

<p>Patients are generally ok once they start treatment and stay on life-long replacement.<br></br>Adherence is high since non-adherence results in uncomfortable symptoms.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

<p>Define alcohol withdrawal.</p>

A

<p>Alcohol withdrawal syndrome (AWS), commonly referred to as 'the shakes', occurs in patients with alcohol dependence when their daily alcohol consumption is decreased or stopped. The syndrome typically begins within 4 to 12 hours after the patient's last drink, and may progress to potentially fatal <strong>delirium tremens</strong>.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

<p>Explain the aetiology of alcohol withdrawal.</p>

A

<p>Chronic alcohol use results in up-regulation of postsynaptic NMDA receptors and down-regulation of post-synaptic GABA receptors. A decrease in blood ethanol concentration due to abrupt cessation in alcohol consumption results in an imbalance between stimulatory (NMDA) and inhibitory (GABA) systems in the central nervous system. Excessive stimulatory effect leads to the development of the clinical signs and symptoms of AWS.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

<p>Explain the risk factors of alcohol withdrawal.</p>

A

<p>Risk factors include having a history of AWS or delirium tremens, as well as sudden withdrawal of alcohol.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

<p>Summarise the epidemiology of alcohol withdrawal.</p>

A

<p>In the US, the 2016 National Survey on Drug Use and Health found that 5.2% of adults over 26 years, 10.7% of adults aged 18-25 years, and 2.0% of youths (aged 12 to 17 years) suffer from alcohol use disorder.<br></br>It is estimated that of these alcohol-dependent patients, approximately 50% will experience symptoms of alcohol withdrawal upon reduced alcohol intake.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

<p>Recognise the presenting symptoms of alcohol withdrawal. Recognise the signs of alcohol withdrawal.</p>

A

<p>Hallucinations<br></br>Change in mental status<br></br>Tremor<br></br>Nausea and vomiting<br></br>Hypertension<br></br>Seizures</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

<p>Identify appropriate investigations for alcohol withdrawal and interpret the results.</p>

A

<p>Serum urea and creatinine<br></br>Liver function tests<br></br>Ethanol<br></br>Electrolyte panel<br></br>FBC<br></br>CT of head<br></br>CXR</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

<p>Generate a management plan for alcohol withdrawal.</p>

A

<p>Benzodiazepine or clomethiazole (+ supportive care)</p>

<p><u>Adjunct:</u><br></br>Phenobarbital<br></br>Vitamin supplementation</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

<p>Identify the possible complications of alcohol withdrawal and its management.</p>

A

<p>Over-sedation<br></br>Delirium tremens<br></br>Alcohol withdrawal seizures<br></br>Status epilepticus<br></br>Death</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

<p>Summarise the prognosis for patients with alcohol withdrawal.</p>

A

<p>Patients may complain of persistent insomnia and autonomic symptoms for a few months after acute withdrawal phase. These symptoms usually last about 6 months. About 50% of patients remain abstinent for a year.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

<p>Define anaphylaxis.<br></br></p>

A

<p><strong>An acute, systemic and life-threatening allergic response to a trigger </strong>caused by the release of immune and inflammatory mediators from basophils and mast cells. At least two organ systems are involved, such as the skin, the upper and lower airways, and the cardiovascular, neurological, and gastrointestinal systems, in this order of priority or in combination.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

<p>Explain the aetiology/risk factors of anaphylaxis.<br></br></p>

A

<p>Exposure to allergen in pre-sensitised individuals is the cause of immune-mediated anaphylaxis. Common allergens include drugs, foods, and insect stings, but exercise with or without the presence of an allergen may also be a trigger. Sometimes, a cofactor (such as an NSAID, alcohol, or another food) is required to provoke food-associated and exercise-induced anaphylaxis.<br></br>The most common trigger (up to ⅓ of cases) is food.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

<p>Summarise the epidemiology of anaphylaxis.<br></br></p>

A

<p>Anaphylaxis is under-reported and it is difficult to estimate as study definitions and criteria are not always comparable. The incidence of food allergic reactions that are coded as anaphylaxis is highest in young children. In children, food allergy is most prevalent in the industrialised world and the emerging economies of southeast Asia, possibly due to an increased exposure to processed food.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

<p>Recognise the presenting symptoms of anaphylaxis.<br></br></p>

A

<p>Rapidly progressive upper airway obstruction<br></br>Rash<br></br>Bronchospasm<br></br>Hypotension or cardiovascular collapse<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

<p>Recognise the signs of anaphylaxis on physical examination.</p>

A

<p>The patient appears agitated, confused, and either flushed or pale. Neurological manifestations also include dizziness, visual disturbances, tremor, disorientation, syncope, and seizures.<br></br>Wheezing, an over-inflated chest, the use of accessory muscles, and preference for the forward-leaning position point to bronchoconstriction. Cardiovascular collapse may occur in addition to hypotension.<br></br>Nearly all adults will show skin manifestations of systemic mediator release, such as rash, erythema, or urticaria. These features might be overshadowed by the more dramatic respiratory and cardiovascular symptoms. Abdominal pain, nausea, vomiting, and diarrhoea are common symptoms.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

<p>Identify appropriate investigations for anaphylaxis and interpret the results.<br></br></p>

A

<p>During the anaphylactic shock, no investigations are useful as they take too long.<br></br>Serum tryptase level.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

<p>Generate a management plan for anaphylaxis. Identify the possible complications of anaphylaxis and its management.<br></br></p>

A

<p><strong>INITIAL</strong><br></br>Cardiorespiratory assessment + supportive measures<br></br>IM adrenaline (epinephrine)<br></br>Assess and secure airway<br></br>IV normal saline</p>

<p><strong>Cardiopulmonary arrest</strong><br></br>CPR and IV adrenaline (epinephrine)</p>

<p><strong>Severe hypotension</strong><br></br>IV adrenaline (epinephrine)<br></br>IV glucagon</p>

<p><strong>Persistent respiratory symptom</strong><br></br>Inhaled beta-2 agonist</p>

<p><strong>Symptomatic hives and rhinorrhoea</strong><br></br>H1 antagonist and H2 antagonist</p>

<p><strong>Post-emergency stabilisation</strong><br></br>Corticosteroids<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

<p>Summarise the prognosis for patients with anaphylaxis.</p>

A

<p>Individuals with previous reactions are at higher risk for recurrence. However, the severity of the previous reaction does not necessarily predict the severity of a subsequent reaction.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

<p>Define aspirin overdose.</p>

A

<p>Potentially fatal poisoning occurring as a result of ingestion or, rarely, topical exposure to salicylates. Can present acutely or indolently with more chronic exposure.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

<p>Explain the aetiology/risk factors of aspirin overdose.</p>

A

<p>The most common source of salicylate poisoning is aspirin (acetylsalicylic acid), which is rapidly hydrolysed to salicylate in the gastrointestinal tract and bloodstream.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

<p>Summarise the epidemiology of aspirin overdose.</p>

A

<p>In the UK, deaths by suicidal overdose of analgesics, including salicylates, were reduced by 22% in the year immediately after the introduction in 1998 of legislation limiting the pack size of analgesics that could be purchased.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

<p>Recognise the presenting symptoms of aspirin overdose. Recognise the signs of aspirin overdose on physical examination.</p>

A

<p>Nausea, vomiting, haematemesis, epigastric pain<br></br>Fever and diaphoresis<br></br>Shortness of breath<br></br>Tachypnoea, hyperpnoea, Kussmaul's respirations<br></br>Tinnitus and/or deafness<br></br>Malaise and/or dizziness<br></br>Movement disorders, asterixis, stupor<br></br>Confusion and/or delirium (irritability, hallucinations)<br></br>Coma and/or papilloedema<br></br>Seizures</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

<p>Identify appropriate investigations for aspirin overdose and interpret the results.</p>

A

<p>ABG<br></br>Serum electrolyte panel<br></br>Serum salicylate level<br></br>Serum urea and creatinine<br></br>Serum ketones<br></br>Blood glucose<br></br>FBC<br></br>Serum LFTs<br></br>Serum PT, activated PTT, INR<br></br>Toxicology screen<br></br>CXR<br></br>ECG</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

<p>Define asthma.<br></br></p>

A

<p>Asthma is a chronic inflammatory airway disease characterised by intermittent airway obstruction and hyper-reactivity.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

<p>Explain the aetiology/risk factors of asthma.<br></br></p>

A

<p>Patients' genetic make-up may predispose them to hyper-responsiveness to environmental aetiological triggers. Those triggers include viral infections (e.g. rhinovirus, respiratory syncytial virus, human metapneumovirus, and influenza virus), bacterial infections (e.g. Mycoplasma pneumoniae or Chlamydia pneumoniae), allergen exposure (e.g. tree, grass, or weed pollen; fungi; or indoor allergens), occupational exposures (e.g. animal or chemical), food additives and chemicals (e.g. metabisulfites), irritants, or aspirin in predisposed people.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

<p>Summarise the epidemiology of asthma.<br></br></p>

A

<p>Asthma affects approximately 30 million people in Europe and more than 25 million people in the US. The global burden is reported to be 300 million people, potentially increasing to 400 million by 2025. In 2010, overall asthma prevalence in the US was 8.4%.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

<p>Recognise the presenting symptoms of asthma.<br></br></p>

A

<p>Recurrent episodes of dyspnoea, chest tightness, wheezing, or coughing typically occur.<br></br>The patient's medical history may help to identify allergen exposures that worsen asthma: for example, episodes may be exacerbated by exposure to irritants such as tobacco smoke or fumes from chemicals, such as bleach. Attacks may occur seasonally or upon exposure to cats in allergic patients. Exercise can also make the symptoms worse.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

<p>Recognise the signs of asthma on physical examination.<br></br></p>

A

<p>The examination may be normal in patients with bronchial asthma. Examination of the nasal passages may reveal nasal polyposis or nasal congestion. Chest auscultation may reveal expiratory wheezes.<br></br>With more severe asthma, wheezes may be audible without the use of a stethoscope. In patients with severe exacerbations, the lung examination may be silent.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

<p>Identify appropriate investigations for asthma and interpret the results.<br></br></p>

A

<p>FEV1/FVC ratio - <80% of predicted<br></br>FEV1 - 20% drop is indicative<br></br>Peak expiratory flow rate (PEFR)<br></br>CXR - normal or hyperinflated<br></br>FBC - normal or raised eosinophils and neutrophils<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

<p>Generate a management plan for asthma.<br></br></p>

A

<p>Salbutamol inhaler until in hospital.<br></br>Once in hospital, administer 2.5mg salbutamol and oxygen as a nebuliser back to back (or 5mg in one dose but this increases the risk of tremor etc). Give IV hydrocortisone or oral prednisolone depending on how bad the patient is.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

<p>Identify the possible complications of asthma and its management.<br></br></p>

A

<p>IV magnesium sulfate in life-threatening exacerbation of asthma.<br></br>Airway remodelling due to inflammation which leads to the airway resembling COPD.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

<p>Summarise the prognosis for patients with asthma.<br></br></p>

A

<p>People with asthma have the same life expectancy as normal people.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

<p>Define acute cardiac failure.<br></br></p>

A

<p>Heart failure is defined clinically as a syndrome in which patients have symptoms and signs resulting from an abnormality of cardiac structure and/or function. Acute heart failure refers to rapid onset or worsening of symptoms and/or signs of heart failure, requiring urgent evaluation and treatment.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

<p>Explain the aetiology/risk factors of acute cardiac failure.<br></br></p>

A

<p>Decompensation of pre-existing chronic heart failure<br></br>Other heart conditions such as aortic regurgitation<br></br>Lack of compliance with medical treatment<br></br>Volume overload<br></br>Infections<br></br>Severe brain insult<br></br>After major surgery<br></br>Reduction of renal function<br></br>Drug abuse<br></br>Phaeochromocytoma<br></br>High output syndromes (Septicaemia, Thyrotoxic crisis, Anaemia, Shunt syndromes)<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

<p>Summarise the epidemiology of acute cardiac failure.</p>

A

<p>Heart failure is the most common indication for hospitalisation in the US, and acute decompensated heart failure is the most common cause for hospitalisation among patients >65 years.<br></br>The average age of people with heart failure in studies conducted in Europe is also older than 70 years, with slight predominance of men.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

<p>Recognise the presenting symptoms of acute cardiac failure.<br></br></p>

A

<p>Dyspnoea<br></br>Decreased exercise tolerance<br></br>Swelling of the legs<br></br>Fatigue<br></br>Generalised weakness<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

<p>Recognise the signs of acute cardiac failure on physical examination.</p>

A

<p>Reduced cardiac output<br></br>Tissue hypoperfusion<br></br>Increased pulmonary pressure<br></br>Tissue congestion<br></br>Raised JVP<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

<p>Identify appropriate investigations for acute cardiac failure and interpret the results.<br></br></p>

A

<p>ECG<br></br>Echocardiogram<br></br>CXR<br></br>Hb<br></br>TFT<br></br>Troponin<br></br>B-type natriuretic peptide (BNP)<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

<p>Generate a management plan for acute cardiac failure.<br></br></p>

A

<p>Loop diuretic in order to get rid of oedema, and then ACEi after the patient stabilises.<br></br>Treatment is generally with ACEi and beta blockers.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

<p>Identify the possible complications of acute cardiac failure and its management.<br></br></p>

A

<p><strong>ARRHYTHMIAS</strong><br></br>Hypotension, hyperkalaemia and headaches may result from treatment.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

<p>Summarise the prognosis for patients with acute cardiac failure.<br></br></p>

A

<p>In hospital, mortality ranges from 2% to 20% depending on clinical factors found on admission.<br></br>Predictors of adverse outcomes include: hypotension, renal dysfunction, older age, male sex, ischaemic congestive heart failure (CHF), previous CHF, respiratory rate on admission >30/minute, anaemia, hyponatraemia, elevated troponin, elevated B-type natriuretic peptide, and other comorbidities such as cancer.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

<p>Define burns injury.</p>

A

<p>Burns are very common injuries, predominantly to the skin and superficial tissues, caused by heat from hot liquids, flame, or contact with heated objects, electrical current, or chemicals.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

<p>Explain the aetiology/risk factors of burns injury.</p>

A

<p>Thermal burns<br></br>Electrical burns<br></br>Chemical burns<br></br>Non-accidental burns</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

<p>Summarise the epidemiology of burns injury.</p>

A

<p>In the UK, 250,000 people are injured by burns. Approximately 175,000 people visit accident and emergency departments with burn injuries. Around 13,000 of them are admitted to hospital for treatment.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

<p>Recognise the presenting symptoms of burns injury. Recognise the signs of burns injury on physical examination.</p>

A

<p>Pain<br></br>Redness</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

<p>Identify appropriate investigations for burns injury and interpret the results.</p>

A

<p>Full blood count<br></br>Metabolic panel<br></br>Carboxyhaemoglobin<br></br>Arterial blood gas<br></br>Fluorescein staining<br></br>Computed tomography scan of head and spine<br></br>Wound biopsy culture<br></br>Wound histology</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

<p>Define cardiac arrest.</p>

A

<p>Sudden loss of cardiac systolic function. It is the result of 4 specific cardiac rhythm disturbances: <strong>ventricular fibrillation (VF), pulseless ventricular tachycardia (VT), pulseless electrical activity, and asystole</strong>. Each of these rhythms may present in different clinical scenarios, though VT and VF are the most common causes of sudden cardiac arrest.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

<p>Explain the aetiology/risk factors of cardiac arrest.</p>

A

<p>Myocardial ischaemia/infarction</p>

<p>Hypovolaemia</p>

<p>Hypoxia</p>

<p>Pulmonary embolism.</p>

<p></p>

<p>Other potential causes of cardiac arrest, all of which require emergent treatment, including hyperkalaemia, hydrogen ion excess (acidosis), hypothermia, hypo- or hyperglycaemia, trauma, tension pneumothorax,toxins, and cardiac tamponade.</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

<p>Summarise the epidemiology of cardiac arrest.<br></br></p>

A

<p>In Europe, out-of-hospital cardiac arrest incidence for patients considered for resuscitation by emergency medical services has been reported as 84 per 100,000 population per year.<br></br>Survival is estimated at <20% for patients presenting out-of-hospital with VF, and <10% overall for patients presenting with out-of-hospital cardiac arrest. In contrast, 36% of patients with VF/ventricular tachycardia (VT) and 11% of patients with pulseless electrical activity/asystole, presenting in-hospital, survive to discharge.<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

<p>Recognise the presenting symptoms of cardiac arrest. Recognise the signs of cardiac arrest on physical examination.<br></br></p>

A

<p>Family history of sudden cardiac arrest<br></br>Pulmonary disease<br></br>Chest pain<br></br>Palpitations- possibility of pre-existing arrhythmias<br></br>Syncope<br></br>Tachycardia<br></br>Unusual heart sounds</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

<p>Identify appropriate investigations for cardiac arrest and interpret the results.<br></br></p>

A

<p>ECG<br></br>FBC<br></br>Serum electrolytes<br></br>ABG<br></br>Cardiac biomarkers<br></br>Toxicology screen<br></br>CXR<br></br>Echocardiogram<br></br>Coronary angiography<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

<p>Generate a management plan for cardiac arrest.<br></br></p>

A

<p><strong>INITIAL</strong><br></br>CPR</p>

<p><strong>ACUTE</strong><br></br>Shockable rhythms (pulseless ventricular tachycardia or ventricular fibrillation)<br></br>CPR and defibrillation<br></br>Adrenaline (epinephrine)<br></br>Adjunct<br></br>Magnesium<br></br>Anti-arrhythmic</p>

<p><strong>Non-shockable rhythms (pulseless electrical activity or asystole)</strong><br></br>CPR and adrenaline (epinephrine)</p>

<p><strong>ONGOING</strong><br></br>Return of spontaneous circulation<br></br>Post-resuscitation care<br></br>No return of spontaneous circulation<br></br>Continue or consider termination of resuscitation<br></br></p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

<p>Identify the possible complications of cardiac arrest and its management.</p>

A

<p>Death</p>

<p>Rib and sternal fractures</p>

<p>Anoxic brain injury</p>

<p>Ischaemic liver injury (“shock liver”)</p>

<p>Renal acute tubular necrosis (ATN)</p>

<p>Recurrent cardiac arrest</p>

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

<p>Summarise the prognosis for patients with cardiac arrest.<br></br></p>

A

<p>The outcome of sudden cardiac arrest is generally poor. Early provision of CPR, including compression-only CPR by bystanders in out-of-hospital arrest increases the rate of survival from sudden cardiac arrest. The strongest predictor of survival is bystander CPR.<br></br>Even those who do survive to hospital admission do not always survive to hospital discharge. Furthermore, those who do survive to hospital discharge often have neurological, pulmonary, cardiac, hepatic, renal, or musculoskeletal complications.<br></br>Most important, the neurological outcome of the comatose survivors of sudden cardiac arrest must be carefully assessed. The following characteristics portend death or a poor neurological outcome:<br></br>At 24 hours - loss of corneal reflex, lack of motor response, lack of withdrawal to pain, and loss of pupillary response.<br></br>At 72 hours - lack of motor response.<br></br></p>

76
Q

<p>Define chronic cardiac failure.<br></br></p>

A

<p>A complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. The term “congestive heart failure” (CHF) is reserved for patients with breathlessness and abnormal sodium and water retention resulting in oedema.<br></br></p>

77
Q

<p>Explain the aetiology/risk factors of chronic cardiac failure.<br></br></p>

A

<p>Coronary artery disease<br></br>Hypertension<br></br>Valvular disease<br></br>Myocarditis<br></br></p>

78
Q

<p>Summarise the epidemiology of chronic cardiac failure.</p>

A

<p>The prevalence of CHF in the western world has been estimated at 1% to 2%, and the incidence is thought to approach 5 to 10 per 1000 people per year.<br></br></p>

79
Q

<p>Recognise the presenting symptoms of chronic cardiac failure.</p>

A

<p>Tachycardia (heart rate >120 beats per minute)<br></br>Chest discomfort<br></br>Ankle oedema<br></br>Night cough<br></br>Fatigue, muscle weakness, or tiredness<br></br></p>

80
Q

<p>Recognise the signs of chronic cardiac failure on physical examination.<br></br></p>

A

<p>Dyspnoea<br></br>Neck vein distension<br></br>S3 gallop<br></br>Cardiomegaly<br></br>Hepatojugular reflux<br></br>Rales<br></br>Hepatomegaly<br></br></p>

81
Q

<p>Identify appropriate investigations for chronic cardiac failure and interpret the results.<br></br></p>

A

<p>ECG<br></br>Echocardiogram<br></br>CXR<br></br>B-type natriuretic peptide (BNP)/N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels<br></br>FBC<br></br>Serum electrolytes (including calcium and magnesium)<br></br>Serum creatinine, blood urea nitrogen<br></br>BM<br></br>LFT<br></br>Thyroid function tests (especially thyroid-stimulating hormone [TSH])<br></br>Blood lipids<br></br>Serum ferritin<br></br>Transferrin saturation<br></br></p>

82
Q

<p>Generate a management plan for chronic cardiac failure.<br></br></p>

A

<p>In newly diagnosed patients with CHF, congestion and volume overload should be promptly treated with diuretics, which may be given intravenously in the initial phase. Loop diuretics used for the treatment of heart failure and congestion include furosemide, bumetanide, and torasemide.</p>

<p>In patients with low left ventricular ejection fraction (LVEF), in addition to diuretics, ACE inhibitors, beta-blockers, and aldosterone antagonists (e.g. spironolactone, eplerenone) should be added.</p>

<p>In unstable patients, beta-blockers should be initiated only after stabilisation, optimisation of volume status, and discontinuation of inotropes. Beta-blockers should be initiated at a low dose.</p>

<p>In patients with CHF and reduced LVEF who are hospitalised with exacerbation of heart failure, unless there is evidence of low cardiac output or haemodynamic instability or contraindication, both ACE-inhibitors and beta-blockers should be continued.<br></br></p>

83
Q

<p>Identify the possible complications of chronic cardiac failure and its management.<br></br></p>

A

<p>Pleural effusion<br></br>Chronic renal insufficiency<br></br>Anaemia<br></br>Acute decompensation of chronic heart failure<br></br>Acute renal failure<br></br>Sudden cardiac death<br></br></p>

84
Q

<p>Summarise the prognosis for patients with chronic cardiac failure.<br></br></p>

A

<p>The evaluation of a patient would be incomplete without an initial and periodic assessment of short- and long-term prognosis. However, the likelihood of survival can be determined reliably only in populations and not in individual patients.<br></br>Haemoglobin A1c was also found to be an independent progressive risk factor for cardiovascular death, hospitalisation, and mortality, even in non-diabetic patients.<br></br></p>

85
Q

<p>Define chronic obstructive pulmonary disease (COPD).<br></br></p>

A

<p>COPD is characterised by airflow limitation that is not fully reversible. It encompasses both emphysema and chronic bronchitis.<br></br></p>

86
Q

<p>Explain the aetiology/risk factors of chronic obstructive pulmonary disease (COPD).</p>

A

<p>Tobacco smoking is by far the main risk factor for COPD. It is responsible for 40% to 70% of COPD cases and exerts its effect by causing an inflammatory response, cilia dysfunction, and oxidative injury. Air pollution and occupational exposure are other common aetiologies.<br></br>Oxidative stress and an imbalance in proteases and antiproteases are also important factors in the pathogenesis of COPD, especially in patients with <strong>alpha-1 antitrypsin deficiency</strong>, who have panacinar emphysema that usually presents at an early age.<br></br></p>

87
Q

<p>Summarise the epidemiology of chronic obstructive pulmonary disease (COPD).<br></br></p>

A

<p>COPD is more common in older people, especially those aged 65 years and older. A retrospective study conducted in the UK between 1990 and 1997 estimated COPD prevalence to be 2% in men and 1% in women.</p>

88
Q

<p>Recognise the presenting symptoms of chronic obstructive pulmonary disease (COPD).<br></br></p>

A

<p>Cough<br></br>Shortness of breath<br></br></p>

89
Q

<p>Recognise the signs of chronic obstructive pulmonary disease (COPD) on physical examination.<br></br></p>

A

<p>Barrel chest</p>

<p>Hyperresonance on percussion</p>

<p>Distant breath sounds on auscultation</p>

<p>Poor air movement on auscultation</p>

<p>Wheezing on auscultation</p>

<p>Coarse crackles<br></br></p>

90
Q

<p>Identify appropriate investigations for chronic obstructive pulmonary disease (COPD) and interpret the results.<br></br></p>

A

<p>Spirometry<br></br>Pulse oximetry<br></br>ABG<br></br>CXR<br></br>FBC<br></br>ECG<br></br></p>

91
Q

<p>Generate a management plan for chronic obstructive pulmonary disease (COPD).<br></br></p>

A

<p>Short-acting bronchodilator<br></br></p>

<p><u>Adjunct:</u><br></br>Systemic corticosteroid<br></br>Transition to inhaled corticosteroid<br></br>Airway clearance techniques<br></br>Supplemental oxygen<br></br></p>

92
Q

<p>Identify the possible complications of chronic obstructive pulmonary disease (COPD) and its management.<br></br></p>

A

<p>Cor pulmonale - Right-sided heart failure secondary to long-standing COPD. It is caused by chronic hypoxia and subsequent vasoconstriction in pulmonary vasculature that causes pulmonary hypertension and right-sided heart failure.<br></br>Recurrent pneumonia<br></br>Depression<br></br>Pneumothorax<br></br>Respiratory failure<br></br>Anaemia<br></br>Polycythaemia</p>

93
Q

<p>Summarise the prognosis for patients with chronic obstructive pulmonary disease (COPD).<br></br></p>

A

<p>COPD is a disease with an indeterminate course and variable prognosis. Its prognosis depends on several factors including genetic predisposition, environmental exposures, comorbidities, and, to a lesser degree, acute exacerbations.</p>

94
Q

<p>Define diabetic ketoacidosis.<br></br></p>

A

<p>Diabetic ketoacidosis (DKA) is an acute metabolic complication of diabetes that is potentially fatal and requires prompt medical attention for successful treatment. It is characterised by absolute insulin deficiency and is the most common acute hyperglycaemic complication of <strong>type 1 diabetes mellitus</strong>.<br></br></p>

95
Q

<p>Explain the aetiology/risk factors of diabetic ketoacidosis.<br></br></p>

A

<p>In DKA, there is a reduction in the net effective concentration of circulating insulin along with an elevation of counter-regulatory hormones.<br></br>The two most common precipitating events are inadequate insulin therapy and infection. Underlying medical conditions such as MI or stroke that provoke the release of counter-regulatory hormones are also likely to result in DKA in patients with diabetes. Drugs that affect carbohydrate metabolism, such as corticosteroids, thiazides, pentamidine, sympathomimetic agents (e.g. <strong>dobutamine</strong> and <strong>terbutaline</strong>), second-generation antipsychotic agents, and immune checkpoint inhibitors may contribute to the development of DKA.</p>

96
Q

<p>Summarise the epidemiology of diabetic ketoacidosis.</p>

A

<p>In England, the incidence of hospital admissions for DKA among adults with type 2 diabetes increased 4.24% annually between 1998 and 2013; hospitalisations for DKA in adults with type 1 diabetes increased from 1998 to 2007, and remained static until 2013.<br></br></p>

97
Q

<p>Recognise the presenting symptoms of diabetic ketoacidosis.</p>

A

<p>Polyuria<br></br>Polyphagia<br></br>Polydipsia<br></br>Weight loss<br></br>Weakness<br></br>Nausea or vomiting<br></br>Abdominal pain<br></br>Sunken eyes<br></br></p>

98
Q

<p>Recognise the signs of diabetic ketoacidosis on physical examination.<br></br></p>

A

<p>Dry mucous membranes<br></br>Poor skin turgor<br></br>Tachycardia<br></br>Hypotension<br></br>Kussmaul respiration<br></br>Acetone breath<br></br>Altered mental status<br></br></p>

99
Q

<p>Identify appropriate investigations for diabetic ketoacidosis and interpret the results.</p>

A

<p>BM<br></br>HbA1C<br></br>FBC<br></br>ABG<br></br>Capillary or serum ketones<br></br>Urinalysis<br></br>Serum urea<br></br>Serum creatinine<br></br>Serum sodium<br></br>Serum potassium<br></br>Serum chloride<br></br>Serum magnesium<br></br>Serum calcium<br></br>Serum phosphate<br></br>Serum creatine phosphokinase<br></br>Serum lactate<br></br>LFT<br></br>Serum amylase<br></br>Serum lipase<br></br>Serum osmolality</p>

100
Q

<p>Generate a management plan for diabetic ketoacidosis.</p>

A

<p>The main goals of treatment are:</p>

<ul> <li>Restoration of volume deficits</li> <li>Resolution of hyperglycaemia and ketosis/acidosis</li> <li>Correction of electrolyte abnormalities (potassium level should be >3.3 mmol/L [>3.3 mEq/L] before initiation of insulin therapy; use of insulin in a patient with hypokalaemia may lead to respiratory paralysis, cardiac arrhythmias, and death)</li> <li>Treatment of the precipitating events and prevention of complications</li></ul>

<p>The majority of patients present to the accident and emergency department, where treatment should be initiated. There are several important steps that should be followed in early management:</p>

<ul> <li>Fluid therapy should be started immediately after initial laboratory evaluations.</li> <li>Infusion of isotonic solution of 0.9% sodium chloride at a rate of 1 to 1.5 L/hour should be used for the first hour of fluid therapy.<br></br> </li></ul>

101
Q

<p>Identify the possible complications of diabetic ketoacidosis and its management.<br></br></p>

A

<p>Hypoglycaemia<br></br>Hypokalaemia<br></br>Arterial or venous thromboembolic events<br></br>Non-anion gap hyperchloremic acidosis<br></br>Cerebral oedema/brain injury<br></br>Acute respiratory distress syndrome (ARDS)<br></br></p>

102
Q

<p>Summarise the prognosis for patients with diabetic ketoacidosis.<br></br></p>

A

<p>The mortality rate is 5% in experienced centres. Death is rarely caused by the metabolic complications of hyperglycaemia or ketoacidosis but rather relates to the underlying illness. The prognosis is substantially worsened at the extremes of age and in the presence of coma and hypotension.</p>

103
Q

<p>Define disseminated intravascular coagulation (DIC).</p>

A

<p>DIC is an acquired syndrome characterised by activation of coagulation pathways, resulting in formation of intravascular thrombi and depletion of platelets and coagulation factors.</p>

<p>Thrombi may lead to vascular obstruction/ischaemia and multi-organ failure. Spontaneous bleeding may occur. Generalised bleeding, evidenced by at least 3 unrelated sites, is highly suggestive of DIC.</p>

104
Q

<p>Explain the aetiology/risk factors of disseminated intravascular coagulation (DIC).</p>

A

<p>Disease states that trigger systemic activation of coagulation may lead to DIC. Causes include:</p>

<ul> <li>Sepsis/severe infection, major trauma or burns</li> <li>Some malignancies (acute myelocytic leukemia or metastatic mucin-secreting adenocarcinoma)</li> <li>Obstetric disorders (amniotic fluid embolism, eclampsia, abruptio placentae, retained dead fetus syndrome)</li> <li>Severe organ destruction or failure (severe pancreatitis, acute hepatic failure)</li> <li>Vascular disorders (Kasabach-Merritt syndrome or giant haemangiomas, large aortic aneurysms)</li> <li>Severe toxic or immunological reactions (blood transfusion reaction or haemolytic reactions, organ transplant rejection, snake bite).</li></ul>

105
Q

<p>Summarise the epidemiology of disseminated intravascular coagulation (DIC).</p>

A

<p>Many conditions can cause DIC; therefore, the overall incidence is difficult to determine. Age and sex are not good predictors. Mortality is high. For instance, the presence of DIC in patients with major trauma will result in a significant increase in overall mortality.</p>

106
Q

<p>Recognise the presenting symptoms of disseminated intravascular coagulation (DIC). Recognise the signs of disseminated intravascular coagulation (DIC) on physical examination.</p>

A

<p>Oliguria<br></br>Hypotension<br></br>Tachycardia<br></br>Purpura fulminans, gangrene, or acral cyanosis<br></br>Delirium or coma<br></br>Petechiae, ecchymosis, oozing, or haematuria</p>

107
Q

<p>Identify appropriate investigations for disseminated intravascular coagulation (DIC) and interpret the results.</p>

A

<p>Platelet count<br></br>Prothrombin time (PT)<br></br>Fibrinogen<br></br>D-dimer/fibrin degradation products<br></br>Activated partial thromboplastin time (aPTT)<br></br>Imaging studies or other tests</p>

108
Q

<p>Define encephalitis.</p>

A

<p>Encephalitis is defined as inflammation of the brain parenchyma associated with neurological dysfunction such as altered state of consciousness, seizures, personality changes, cranial nerve palsies, speech problems, and motor and sensory deficits.</p>

109
Q

<p>Explain the aetiology of encephalitis.</p>

A

<p>It is the result of direct inflammation of the brain tissue, as opposed to the inflammation of the meninges (meningitis), and can be the result of infectious or noninfectious causes. An aetiological agent is only identified in around 50% of cases.</p>

110
Q

<p>Explain the risk factors of encephalitis.</p>

A

<p>Age <1 or >65 years<br></br>Immunodeficiency<br></br>Post-infection<br></br>Blood/body fluid exposure<br></br>Organ transplantation<br></br>Animal or insect bites<br></br>Location<br></br>Season<br></br>Swimming or diving in warm freshwater or nasal/sinus irrigation</p>

111
Q

<p>Summarise the epidemiology of encephalitis.</p>

A

<p>Around 2500 cases of encephalitis occur in England each year. Globally, the incidence of encephalitis is around 7 per 100,000 population per year. There is no specific gender predominance, but frequently a bimodal age distribution is seen with highest incidence in those under one year and over 65 years.</p>

112
Q

<p>Recognise the presenting symptoms of encephalitis. Recognise the signs of encephalitis on physical examination.</p>

A

<p>Fever<br></br>Rash<br></br>Altered mental state<br></br>Focal neurological deficit<br></br>Meningismus<br></br>Cough<br></br>Gastrointestinal infection</p>

113
Q

<p>Identify appropriate investigations for encephalitis and interpret the results.</p>

A

<p>FBC<br></br>Peripheral blood smear<br></br>Serum electrolytes<br></br>LFTs<br></br>Blood cultures<br></br>Throat swab<br></br>Nasopharyngeal aspirate<br></br>Sputum culture<br></br>Chest radiography<br></br>CT brain<br></br>MRI brain<br></br>EEG<br></br>CSF analysis<br></br>CSF culture<br></br>CSF serology<br></br>CSF polymerase chain reaction (PCR)</p>

114
Q

<p>Define epilepsy.</p>

A

<p>A disorder which causes seizures. There are many different forms of epilepsy and treatment depends on which form it is.</p>

115
Q

<p>Explain the aetiology/risk factors of epilepsy.</p>

A

<p>Age - The onset of epilepsy is most common in children and older adults, but the condition can occur at any age.<br></br>Family history<br></br>Head injuries<br></br>Stroke and other vascular diseases<br></br>Dementia<br></br>Brain infections<br></br>Seizures in childhood</p>

116
Q

<p>Summarise the epidemiology of epilepsy.</p>

A

<p>Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries.<br></br>It is estimated that up to 70% of people living with epilepsy could live seizure-free if properly diagnosed and treated.</p>

117
Q

<p>Recognise the presenting symptoms of epilepsy. Recognise the signs of epilepsy on physical examination.</p>

A

<p>Symptoms range from generalised tonic-clonic seizures which are easily recognisable due to the whole body to absence seizures which is when people appear to lose focus for 5-10 seconds but otherwise appear perfectly normal and exhibit no other symptoms.</p>

118
Q

<p>Identify appropriate investigations for epilepsy and interpret the results.</p>

A

<p>EEG<br></br>MRI<br></br>fMRI</p>

119
Q

<p>Identify the possible complications of epilepsy (incl. status epilepticus) and its management.</p>

A

<p>The patient may hurt themselves during the seizure by falling. As well as this, prolonged seizures can cause brain damage.<br></br>Breathing in food or saliva into the lungs during a seizure, which can cause aspiration pneumonia.</p>

120
Q

<p>Summarise the prognosis for patients with epilepsy.</p>

A

<p>Prognosis depends on the type and severity of the epilepsy. There is no cure but it can be managed.</p>

121
Q

<p>Define extradural haemorrhage.<br></br></p>

A

<p>A contusion resulting in bleeding into the extradural space. This results in raised intracranial pressure and possibly compression of the brain resulting in neurological disorders and potential death.</p>

122
Q

<p>Explain the aetiology/risk factors of extradural haemorrhage.</p>

A

<p>This is usually caused by trauma with a lot of force.</p>

123
Q

<p>Summarise the epidemiology of extradural haemorrhage.</p>

A

<p>Intracranial epidural hematoma occurs in approximately 2% of patients with head injuries and 5–15% of patients with fatal head injuries.</p>

124
Q

<p>Recognise the signs of extradural haemorrhage on physical examination. Recognise the presenting symptoms of extradural haemorrhage.</p>

A

<p>TRIPHASIC<br></br>There is loss of consciousness followed by a LUCID INTERVAL before the patient’s condition declines again.<br></br>LOC is followed by headache, progressive obtundation, and hemiparesis. Bleeding may eventually cause a “blown pupil” secondary to uncal herniation. The “blown pupil” will be ipsilateral and the hemiparesis will be contralateral.<br></br></p>

125
Q

<p>Identify appropriate investigations for extradural haemorrhage and interpret the results.</p>

A

<p>CT scan - Will show characteristic bi-convex mass within the skull if there is an EDH is present (“lemon-shaped” as opposed to the typical “banana-shape” of subdural haemorrhages).<br></br>MRI - Takes longer so is not suitable for first line but can be useful after surgery in order to determine if there is ischaemia of the brain.</p>

126
Q

<p>Define ischaemic heart disease.</p>

A

<p>Part of the myocardium dies due to lack of oxygen. This results in chest pain and reduced efficiency. It can be caused by a thrombus or an embolus.</p>

127
Q

<p>Explain the aetiology/risk factors of ischaemic heart disease.</p>

A

<p>Smoking<br></br>Obesity<br></br>Sedentary lifestyle<br></br>Family history<br></br>Hypertension</p>

128
Q

<p>Summarise the epidemiology of ischaemic heart disease.</p>

A

<p>Epidemiology of ischaemic heart disease (IHD) Cardiovascular disease (CVD) is the most common cause of death in Europe, accounting for more than 4 million deaths each year. This corresponds to 45% of all deaths; 49% among women and 40% among men.</p>

129
Q

<p>Recognise the presenting symptoms of ischaemic heart disease.</p>

A

<p>Chest pain<br></br>Shortness of breath<br></br>Epigastric discomfort<br></br>Pain radiating to the jaw or arm<br></br>Nausea/vomiting<br></br>Perspiration (diaphoresis)<br></br>Fatigue</p>

130
Q

<p>Recognise the signs of ischaemic heart disease on physical examination.</p>

A

<p>Tachycardia<br></br>S3<br></br>Mitral regurgitation murmur<br></br>Bibasilar rales<br></br>Aortic outflow murmur<br></br>Carotid bruit<br></br>Diminished peripheral pulses<br></br>Signs of abdominal aortic aneurysm<br></br>Retinopathy seen on fundoscopic examination<br></br>Xanthomas or xanthelasma</p>

131
Q

<p>Identify appropriate investigations for ischaemic heart disease and interpret the results.</p>

A

<p>CXR<br></br>ECG<br></br>Echocardiogram<br></br>Troponin<br></br>Creatine kinase<br></br>BNP<br></br>FBC<br></br>Urea and serum creatinine<br></br>LFT<br></br>BM</p>

132
Q

<p>Generate a management plan for ischaemic heart disease.</p>

A

<p>Determine the cause of the ischaemic heart disease.<br></br>Potentially give oxygen and anti-platelets in the acute phase.</p>

133
Q

<p>Identify the possible complications of ischaemic heart disease and its management.</p>

A

<p>Brain damage due to hypoxia. Decreased quality of life due to dyspnea during exercise.</p>

134
Q

<p>Summarise the prognosis for patients with ischaemic heart disease.</p>

A

<p>Increased risk of further cardiac events in the future. The risk varies depending on personal factors.</p>

135
Q

<p>Define meningitis.</p>

A

<p>Bacterial meningitis is a serious inflammation of the meninges caused by various bacteria.</p>

136
Q

<p>Explain the aetiology of meningitis.</p>

A

<p><em>Streptococcus pneumoniae</em>, <em>Neisseria meningitidis</em>, and <em>Haemophilus influenzae</em> type b (Hib) are the predominant causative pathogens in both adults and children.</p>

137
Q

<p>Explain the risk factors of meningitis.</p>

A

<p>≤5 or ≥65 years of age<br></br>Crowding<br></br>Exposure to pathogens<br></br>Non-immunised infants<br></br>Immunodeficiency<br></br>Cancer<br></br>Asplenia/hyposplenic state<br></br>Cranial anatomical defects<br></br>Cochlear implants</p>

138
Q

<p>Summarise the epidemiology of meningitis.</p>

A

<p>The incidence of bacterial meningitis in Western countries and the US is 0.7 to 0.9 per 100,000 persons per year and has decreased by 3% to 4% in the past 10 to 20 years.</p>

139
Q

<p>Recognise the presenting symptoms of meningitis. Recognise the signs of meningitis on physical examination.</p>

A

<p>Stiff neck<br></br>Photophobia<br></br>Headache<br></br>Fever<br></br>Confusion<br></br>Vomiting<br></br>Non-blanching rash</p>

140
Q

<p>Identify appropriate investigations for meningitis and interpret the results.</p>

A

<p>LP<br></br>FBC<br></br>CRP<br></br>Blood culture</p>

141
Q

<p>Generate a management plan for meningitis.</p>

A

<p>Empirical antibiotic therapy</p>

<p><u>Plus:</u><br></br>Supportive therapy<br></br>Dexamethasone</p>

142
Q

<p>Identify the possible complications of meningitis and its management.</p>

A

<p>Shock<br></br>Elevated intracranial pressure<br></br>Hydrocephalus<br></br>Cognitive, academic, and behavioural problems<br></br>Seizures<br></br>Subdural effusion<br></br>Hearing loss<br></br>Brain abscess<br></br>Septic deep vein thrombosis</p>

143
Q

<p>Summarise the prognosis for patients with meningitis.</p>

A

<p>Generally, with prompt and adequate antimicrobial and supportive therapy, the outcome after acute bacterial meningitis is excellent. However, prognosis does depend on multiple factors such as age, presence of comorbidity, causative pathogen, and severity at presentation.</p>

144
Q

<p>Define multi-organ dysfunction syndrome.</p>

A

<p>Multi-organ dysfunction syndrome (MODS) is also known as multiple organ failure and is altered organ function in an acutely ill patient requiring medical intervention to achieve homeostasis.</p>

145
Q

<p>Explain the aetiology/risk factors of multi-organ dysfunction syndrome.</p>

A

<p>The condition usually results from infection, injury (accident, surgery), hypoperfusion and hypermetabolism. The primary cause triggers an uncontrolled inflammatory response. Sepsis is the most common cause of MODS and may result in septic shock.</p>

146
Q

<p>Summarise the epidemiology of multi-organ dysfunction syndrome.</p>

A

<p>Epidemiology is unknown.</p>

147
Q

<p>Recognise the presenting symptoms of multi-organ dysfunction syndrome. Recognise the signs of multi-organ dysfunction syndrome on physical examination.</p>

A

<p><u><strong>Stage 1:</strong></u> The patient has increased volume requirements and mild respiratory alkalosis which is accompanied by oliguria, hyperglycemia and increased insulin requirements.<br></br><u><strong>Stage 2:</strong></u> The patient is tachypneic, hypercapnic and hypoxemic; develops moderate liver dysfunction and possible hematologic abnormalities.<br></br><u><strong>Stage 3: </strong></u>The patient develops shock with azotemia and acid-base disturbances; has significant coagulation abnormalities.<br></br><u><strong>Stage 4:</strong></u> The patient is vasopressor dependent and oliguric or anuric; subsequently develops ischemic colitis and lactic acidosis.</p>

148
Q

<p>Identify appropriate investigations for multi-organ dysfunction syndrome and interpret the results.</p>

A

<p>Investigations are to identify the cause of multi-organ dysfunction syndrome so there is a huge variety of tests you can do.</p>

149
Q

<p>Summarise the prognosis for patients with multi-organ dysfunction syndrome.</p>

A

<p>At present there is no drug or device that can reverse organ failure that has been judged by the health care team to be medically and/or surgically irreversible. Mortality varies from 30% to 100% where the chance of survival is diminished as the number of organs involved increases. Since the 1980s the mortality rate has not changed.</p>

150
Q

<p>Define opiate overdose.</p>

A

<p>An opioid overdose occurs when larger quantities than physically tolerated are taken, resulting in central nervous system and respiratory depression.</p>

151
Q

<p>Explain the aetiology/risk factors of opiate overdose.</p>

A

<p>Opioid abuse and dependence<br></br>Recent abstinence in chronic users<br></br>Chronic pain</p>

152
Q

<p>Summarise the epidemiology of opiate overdose.</p>

A

<p>Opioid abuse and overdose is a growing problem worldwide. In the US, from 1991 to 2015 the number of opioid-related deaths quadrupled.</p>

153
Q

<p>Recognise the presenting symptoms of opiate overdose. Recognise the signs of opiate overdose on physical examination.</p>

A

<p>Presence of risk factors<br></br>Miosis<br></br>Bradypnoea<br></br>Altered mental status<br></br>Dramatic response to naloxone<br></br>Fresh needle marks<br></br>Drug paraphernalia nearby<br></br>Decreased gastrointestinal motility<br></br>Old track marks on arms and legs</p>

154
Q

<p>Identify appropriate investigations for opiate overdose and interpret the results.</p>

A

<p>Therapeutic trial of naloxone<br></br>Electrocardiogram (ECG)</p>

155
Q

<p>Define paracetamol overdose.</p>

A

<p>Taking too much paracetamol which results in generation of hepatotoxic metabolites. Overdose may occur after an acute single ingestion of a large amount of paracetamol or paracetamol-containing medication, or repeated ingestion of an amount exceeding the recommended dosage.</p>

156
Q

<p>Explain the aetiology/risk factors of paracetamol overdose.</p>

A

<p>Paracetamol is usually metabolised by glucuronidation, however, when these enzymes are saturated, the paracetamol is metabolised by the CYP450 system (specifically CYP3A4 and CYP2E1) which generates NAPQI which is a toxic metabolite.</p>

<p>Paracetamol overdose can be a suicide method due to its accessibility, however it seems that a lot of people are unaware of its harmful effects so is not a popular method by people attempting suicide. Death comes in the form of liver failure a few weeks later.</p>

157
Q

<p>Summarise the epidemiology of paracetamol overdose.</p>

A

<p>Paracetamol is easily accessible and often people take too much by accident by taking paracetamol along with other medication containing paracetamol.</p>

158
Q

<p>Recognise the presenting symptoms of paracetamol overdose. Recognise the signs of paracetamol overdose on physical examination.</p>

A

<p>Patients are often asymptomatic or have only mild gastrointestinal symptoms at initial presentation. Untreated paracetamol poisoning may cause varying degrees of liver injury over the 2 to 4 days following ingestion, including fulminant hepatic failure.</p>

<p>Rarely, massive overdose may initially present with coma and severe metabolic acidosis. Presentation with coma may also occur if a combination preparation of paracetamol and opioid is taken in overdose, or after an overdose of multiple drugs.</p>

<p>Hepatotoxicity is extremely rare in patients treated with acetylcysteine within 8 hours of an acute paracetamol overdose. The efficacy of acetylcysteine decreases subsequent to the first 8 hours following an acute paracetamol overdose, with a corresponding stepwise increase in hepatotoxicity with increasing treatment delays between 8 and 16 hours.<br></br></p>

159
Q

<p>Identify appropriate investigations for paracetamol overdose and interpret the results.</p>

A

<p>Serum paracetamol level<br></br>Serum AST and ALT<br></br>Arterial pH and lactate level<br></br>Urea and electrolytes or tests of renal function<br></br>Serum prothrombin time and INR - Used to monitor extent of hepatotoxicity</p>

160
Q

<p>Define haemorrhagic stroke.</p>

A

<p>Stroke is defined as an acute neurological deficit lasting more than 24 hours and caused by cerebrovascular aetiology.</p>

161
Q

<p>Explain the aetiology/risk factors of haemorrhagic stroke.</p>

A

<p>Hypertension<br></br>Advanced age<br></br>Male sex<br></br>Asian, black and/or Hispanic<br></br>Family history of haemorrhagic stroke<br></br>Haemophilia<br></br>Cerebral amyloid angiopathy<br></br>Anticoagulation</p>

162
Q

<p>Summarise the epidemiology of haemorrhagic stroke.</p>

A

<p>Stroke is the third leading cause of death and a major cause of disability in the US and in England and Wales. Haemorrhagic strokes account for 15% of all strokes.</p>

163
Q

<p>Recognise the presenting symptoms of haemorrhagic stroke. Recognise the signs of haemorrhagic stroke on physical examination.</p>

A

<p>Neck stiffness<br></br>History of atrial fibrillation<br></br>History of liver disease<br></br>Visual changes<br></br>Photophobia<br></br>Sudden onset<br></br>Altered sensation<br></br>Headache<br></br>Weakness<br></br>Sensory loss<br></br>Aphasia<br></br>Dysarthria<br></br>Ataxia</p>

164
Q

<p>Identify appropriate investigations for haemorrhagic stroke and interpret the results.</p>

A

<p>Non-infused head CT<br></br>Chemistry panel<br></br>FBC<br></br>Clotting tests<br></br>ECG<br></br>Platelet function test<br></br>Urine drug screen<br></br>Pregnancy test in women of childbearing age<br></br>Liver function test<br></br>Intracerebral haemorrhage (ICH) Score</p>

165
Q

<p>Generate a management plan for haemorrhagic stroke.</p>

A

<p>Neurosurgical and neurocritical care evaluation</p>

<p><u>Plus:</u><br></br>Admission to neuroscience ICU or stroke unit<br></br>Airway protection<br></br>Aspiration precautions</p>

166
Q

<p>Identify the possible complications of haemorrhagic stroke and its management.</p>

A

<p>Deep venous thrombosis<br></br>Infection<br></br>Seizures<br></br>Delirium<br></br>Aspiration pneumonia<br></br>Hydrocephalus</p>

167
Q

<p>Summarise the prognosis for patients with haemorrhagic stroke.</p>

A

<p>Mortality is significantly higher than for ischaemic stroke, in the range of 35% to 40%. Only 20% to 30% of all patients are well enough to live independently by 3 to 6 months.</p>

168
Q

<p>Define ischaemic stroke.</p>

A

<p>Stroke is defined as an acute neurological deficit lasting more than 24 hours and caused by cerebrovascular aetiology.</p>

169
Q

<p>Explain the aetiology/risk factors of ischaemic stroke.</p>

A

<p>Older age<br></br>Family history of stroke<br></br>Hypertension<br></br>Smoking<br></br>Diabetes mellitus<br></br>Atrial fibrillation<br></br>Comorbid cardiac conditions<br></br>Carotid artery stenosis<br></br>Sickle cell disease<br></br>Dyslipidaemia</p>

170
Q

<p>Summarise the epidemiology of ischaemic stroke.</p>

A

<p>The most common type of stroke. Stroke is the third leading cause of death and a major cause of disability in the US and in England and Wales.</p>

171
Q

<p>Recognise the presenting symptoms of ischaemic stroke. Recognise the signs of ischaemic stroke on physical examination.</p>

A

<p>Vision loss or visual field deficit<br></br>Weakness<br></br>Aphasia<br></br>Impaired coordination (ataxia)<br></br>Sudden onset of symptoms<br></br>Negative symptoms (i.e., loss of function)<br></br>Altered sensation<br></br>Headache<br></br>Diplopia<br></br>Sensory loss<br></br>Dysarthria<br></br>Gaze paresis<br></br>Arrhythmias, murmurs, or pulmonary oedema</p>

172
Q

<p>Identify appropriate investigations for ischaemic stroke and interpret the results.</p>

A

<p>CT head<br></br>MRI brain<br></br>Serum glucose<br></br>Serum electrolytes<br></br>Serum urea and creatinine<br></br>Cardiac enzymes<br></br>ECG<br></br>FBC<br></br>Prothrombin time and PTT (with international normalised ratio)</p>

173
Q

<p>Generate a management plan for ischaemic stroke within 4.5 hours and no contraindication to thrombolysis.</p>

A

<p>Alteplase (recombinant tissue plasminogen activator or r-tPA)</p>

<p><u>Adjunct:</u><br></br>Aspirin 24 hours after r-tPA<br></br>Endovascular intervention (stent retriever)<br></br><u>Plus:</u><br></br>Supportive care<br></br>Swallowing assessment<br></br>VTE prophylaxis + early mobilisation</p>

174
Q

<p>Generate a management plan for ischaemic stroke after 4.5 hours or contraindication to thrombolysis.</p>

A

<p>Aspirin</p>

<p><u>Plus:</u><br></br>Supportive care<br></br>Swallowing assessment<br></br><u>Adjunct:</u><br></br>VTE prophylaxis + early mobilisation</p>

175
Q

<p>Identify the possible complications of ischaemic stroke and its management.</p>

A

<p>Deep venous thrombosis (DVT)<br></br>Seizure<br></br>Haemorrhagic transformation of ischaemic stroke<br></br>r-tPA-related orolingual oedema<br></br>Brain oedema and elevated intracranial pressure<br></br>Depression<br></br>Aspiration pneumonia</p>

176
Q

<p>Summarise the prognosis for patients with ischaemic stroke.</p>

A

<p>In 2013, a total of 3.3 million individuals died of ischaemic stroke worldwide. Between 1990 and 2010, ischaemic stroke mortality decreased 37% in high-income countries and 14% in low- and middle-income countries.</p>

177
Q

<p>Define subarachnoid haemorrhage.</p>

A

<p>Subarachnoid haemorrhage (SAH) is bleeding into the subarachnoid space and is an emergency. The most common cause of non-traumatic SAH is intracranial aneurysm. Aneurysmal SAH causes substantial morbidity and mortality. When a cerebral aneurysm ruptures, blood flows into the subarachnoid space, sometimes seeping into brain parenchyma and/or ventricles. The sudden increase in intracranial pressure, as well as the destructive and toxic effects of blood on brain parenchyma and cerebral vessels, accounts for most complications.</p>

178
Q

<p>Explain the aetiology/risk factors of subarachnoid haemorrhage.</p>

A

<p>Rupture of an intracranial saccular aneurysm is the leading cause of non-traumatic SAH, accounting for approximately 80% of cases. The remaining 20% are attributed to non-aneurysmal perimesencephalic SAH, arteriovenous malformations, arterial dissections, use of anticoagulants, and other rare conditions.</p>

179
Q

<p>Summarise the epidemiology of subarachnoid haemorrhage.</p>

A

<p>The incidence of SAH in most populations is between 6 and 8 cases out of 100,000 per year. In the UK, just over 9000 cases were reported in 2012-2013.<br></br>SAH accounts for about 5% of all strokes.</p>

180
Q

<p>Recognise the presenting symptoms of subarachnoid haemorrhage. Recognise the signs of subarachnoid haemorrhage on physical examination.</p>

A

<p>Headache<br></br>Photophobia<br></br>Loss of consciousness</p>

181
Q

<p>Identify appropriate investigations for subarachnoid haemorrhage and interpret the results.</p>

A

<p>CT - May also show subdural or parenchymal haematoma, hypodensities, hydrocephalus, and sometimes the aneurysm(s) if large or thrombosed.<br></br>FBC<br></br>Clotting profile<br></br>Serum electrolytes<br></br>Troponin I<br></br>ECG</p>

182
Q

<p>Define subdural haemorrhage.</p>

A

<p>A contusion or haemorrhage in the subdural space of the brain.</p>

183
Q

<p>Explain the aetiology / risk factors of subdural haemorrhage.</p>

A

<p>The primary aetiology of both acute and chronic subdural haematomas is trauma. Less commonly, subdural haematomas are associated with rupture of a cerebral aneurysm or vascular malformation (i.e., arteriovenous malformation or dural fistula). There are also case reports in the literature of spontaneous subdural haematomas associated with cerebral hypotension and malignancy.</p>

184
Q

<p>Summarise the epidemiology of subdural haemorrhage.</p>

A

<p>The exact incidence of subdural haematoma is unknown. Acute subdural haematoma is found in about 11% to 20% of patients admitted to hospital with mild to severe traumatic brain injury. Chronic subdural haematomas occur most commonly in older people (age >65 years), and are frequently associated with a history of falls or anticoagulant use.</p>

185
Q

<p>Recognise the presenting symptoms of subdural haemorrhage. Recognise the signs of subdural haemorrhage on physical examination.</p>

A

<p>Evidence of trauma<br></br>Headache<br></br>Nausea/vomiting<br></br>Diminished eye response<br></br>Diminished verbal response<br></br>Diminished motor response<br></br>Confusion</p>

186
Q

<p>Identify appropriate investigations for subdural haemorrhage and interpret the results.</p>

A

<p><u><strong>Non-contrast CT scan</strong></u> - The subdural fluid collection is usually crescentic in shape and can cross suture lines. The age of the haematoma determines the density of the lesion. There may be effacement of the underlying sulci or midline shift, effacement of cisterns or other signs of herniation, or a skull fracture or other intracranial haematomas.</p>

<p>There is no advantage of using an MRI or x-ray. An MRI may be useful after surgery in order to determine the extent of ischaemia and x-ray may be used in order to identify skull fractures which may be due to trauma.</p>

187
Q

<p>Generate a management plan for subdural haemorrhage.</p>

A

<p>All patients on anticoagulation should have their antiplatelet or anticoagulant agent stopped and/or reversed. All patients require serial prothrombin time, partial thromboplastin time, international normalised ratio, and platelet and fibrinogen levels followed.<br></br>In order to reduce ICP, consider raising the head or surgical intervention if it’s severe.</p>